Adma Biologics (ADMA) EBIT Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) EBIT Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 131.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 131.19% |
| Sep 30, 2025 | 95.53% |
| Jun 30, 2025 | 88.19% |
| Mar 31, 2025 | 63.30% |
| Dec 31, 2024 | 69.91% |
| Sep 30, 2024 | 68.05% |
| Jun 30, 2024 | 65.29% |
| Mar 31, 2024 | 50.94% |
| Dec 31, 2023 | 41.39% |
| Sep 30, 2023 | 38.02% |
| Jun 30, 2023 | 69.77% |
| Mar 31, 2023 | 63.54% |
| Dec 31, 2022 | 8.18% |
| Sep 30, 2022 | -0.97% |
| Jun 30, 2022 | 6.82% |
| Mar 31, 2022 | -3.90% |
| Dec 31, 2021 | 7.28% |
| Sep 30, 2021 | -1.54% |
| Jun 30, 2021 | -5.11% |
| Mar 31, 2021 | 2.84% |